Professional background
He advises healthcare companies on topics related to health regulations, litigation, research, drafting and negotiating of contracts.
Sébastien began his career in 1998 as a corporate lawyer for Roche and Schering-Plough, before practising within the "Healthcare Industry" department of Courtois Lebel from 2007. He then developed his own business before joining Fieldfisher Paris in 2016 as Of Counsel.
He speaks French and English.
Authored pieces
Life Sciences
Insight
The European Court of Justice opens the way for chemically synthesised generics of reference biological medicinal products
29.04.2026
In a landmark decision issued last Thursday, the Court of Justice of the European Union ruled that a medicines agency may grant a marketing authorisation for a chemically synthesised product as a generic of a reference biological medicinal product. This decision applies across all EU Member States and is expected to have significant implications for the pharmaceutical sector.
Insight
Brand new compulsory templates for clinical trials in France
12.04.2022
Since Monday 11 April 2022, sponsors who intend to set up clinical trials with French hospitals must use brand new versions of the previous official templates ("Convention Unique ") published in 2016. CROs, pharmaceutical companies and medical device companies are concerned. The two previous versions are cancelled but contracts already signed remain in force (almost 4,000 contracts signed last year).
Lawyers I've worked with
